Logo Image

Podcasts

Clinical Insights on Dyskinesia and Tremor in Parkinson’s Disease

ByDaniel E. Kremens, MD, JD,Fernando Luis Pagan, MD,Yasar Torres-Yaghi, MD

Panelists discuss how distinguishing between dyskinesia (choreoform, dance-like movements) and tremor in Parkinson's disease is crucial for treatment decisions, as modern therapeutic options including extended-release amantadine, continuous subcutaneous delivery systems, and advanced formulations can now effectively manage both motor fluctuations and troublesome dyskinesias simultaneously.

2 experts are featured in this series.

B Cells as a Treatment Target in Myasthenia Gravis

ByAli Habib, MD,Arjun Seth, MD

Ali Habib, MD, and Arjun Seth, MD, discuss how B-cell–targeted therapies represent a promising upstream treatment approach for myasthenia gravis that could provide more sustained efficacy compared with current downstream treatments like complement inhibitors and FcRn antagonists, with CD19-targeting agents like inebilizumab showing particular promise in clinical trials for both acetylcholine receptor and MuSK antibody subtypes.